Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?

AIM: Patients with rectal cancer often undergo multiple CT scans prior to surgical resection. We propose that in patients with locally advanced rectal cancer without evidence of metastatic disease at presentation, CT imaging of the chest and abdomen after preoperative neoadjuvant therapy does not change clinical information or surgical management. METHOD: An institutional review board-approved medical record review identified patients with contrast enhanced CT of the chest, abdomen and pelvis alone or in conjunction with (18)F-fluoro-2-deoxy-d-glucose/positron emission tomography imaging for staging of rectal cancer prior to and after neoadjuvant therapy. Eighty-eight patients were included in the study. Scans were reviewed for the presence of metastatic disease on initial and follow-up imaging prior to surgical resection. RESULTS: Seventy-six (86%) of 88 patients had no evidence of metastasis at presentation. None of these patients developed metastatic disease after neoadjuvant therapy. Twelve (14%) had metastases at presentation. No study patient developed metastatic disease in a new organ. CONCLUSION: Imaging after preoperative neoadjuvant therapy in rectal cancer does not change the designation of metastatic disease. Patients with locally advanced rectal adenocarcinoma without evidence of metastases may not benefit from repeat imaging of the chest and abdomen after neoadjuvant therapy.

3.0- Versus 1.5-T MR cholangiography: a pilot study.

OBJECTIVE: The purpose of our study was to evaluate quantitative and qualitative image quality of MR cholangiography at a field strength of 3.0 T compared with the standard field strength of 1.5 T. MATERIALS AND METHODS: A standardized MR cholangiography sequence protocol was used for 15 healthy male volunteers (mean age +/- SD, 32.4 +/- 4.3 years) who underwent both 1.5- and 3.0-T MRI within 2 hr in an alternating fashion. Dedicated circular polarized torso coils (1.5 and 3.0 T) were used. The sequence protocol included breath-hold single-slice rapid acquisition with relaxation enhancement (slice thickness, 50 mm; orientation, coronal and +/- 20 degrees oblique coronal); breath-hold multislice HASTE (slice thickness, 3 mm; coronal only); and a non-breath-hold, respiratory-triggered 3D turbo spin-echo (TSE) T2-weighted sequence (slice thickness, 1 mm; 60 slices per slab; coronal only). Maximum intensity projections were generated from each multislice data set. Bile duct (common bile duct, right posterior segmental branch, and left hepatic duct) to periductal tissue contrast-to-noise ratios were compared at 1.5 and 3.0 T. Qualitative image analysis was performed by three independent reviewers. Qualitative analysis included delineation of the extra- and intrahepatic biliary anatomy, with specific attention given to the presence (or absence) of cystic or intrahepatic ductal variants, using a 4-point confidence scale. Statistical analysis consisted of the paired Student's t test and the signed rank test. RESULTS: Contrast-to-noise ratios between the bile duct and the periductal tissue were higher at 3.0 T in all three locations (common bile duct, right posterior segmental branch, and left hepatic duct). In each magnet class, the 3D TSE sequence offered the best contrast-to-noise ratio and qualitative analysis. Superiority of the 3D TSE sequence was statistically significant in all analyses. Five of the 15 volunteers had intrahepatic biliary variants that were detected with a higher level of confidence (p < 0.01) on the 3.0-T system than on the 1.5-T system. CONCLUSION: Compared with MR cholangiography at 1.5 T, MR cholangiography at 3.0 T offers improved contrast-to-noise ratio and a higher level of confidence for depicting intrahepatic variants.

Endoscopic ultrasound and computer tomography are inaccurate methods of classifying cystic pancreatic lesions.

BACKGROUND: Despite advances in imaging modalities, preoperative diagnosis of pancreatic cystic lesions remains difficult. AIM: To assess the accuracy of endoscopic ultrasound and computer tomography to preoperatively distinguish benign from potentially malignant and malignant pancreatic cystic lesions. METHODS: Photograph series obtained from endoscopic ultrasound examinations of 66 patients with cystic pancreatic lesions were blindly reviewed by three endoscopic ultrasonographers. Forty-one of those 66 patients also underwent a computer tomography scan at our institution, which was blindly reviewed by a single radiologist. Computer tomography and endoscopic ultrasound classification into benign and malignant and potentially malignant pancreatic cystic lesions was correlated with the final diagnosis, which was established by surgical pathology (n = 43), diagnostic fine needle aspiration (n = 13) or follow-up imaging (n = 10). Interobserver agreement was measured using kappa statistics. RESULTS: Endoscopic ultrasound classification by the three examiners into benign versus malignant or potentially malignant cystic lesions was correct in 65-67%. Interobserver agreement was 50%. Kappa values for pairs of endoscopic ultrasound examiners were 0.16, 0.43 and 0.53. Computer tomography classification was correct in 71% and in agreement with the endoscopic ultrasound classification in 56-61% (kappa 0.12 to 0.27). CONCLUSIONS: Endoscopic ultrasound and computer tomography cannot accurately distinguish between benign pancreatic cystic lesions and malignant or potentially malignant ones. There is poor-to-modest interobserver agreement in classifying these lesions.

Percutaneous biopsy of periarterial soft tissue cuffs in the diagnosis of pancreatic carcinoma.

Pancreatic cancer may present on computed tomography (CT) as an isolated cuff of tumor surrounding the superior mesenteric artery (SMA) or celiac trunk, without an identifiable pancreatic mass. We reviewed our experience with imaging-guided biopsy of the soft tissue cuff in this patient group. A retrospective review of our interventional database identified 163 patients referred for biopsy of suspected pancreatic carcinoma. Of these, eight patients underwent biopsy of an isolated cuff of soft tissue encasing the SMA (n = 6) or celiac trunk (n = 2). None of these eight patients had an identifiable pancreatic mass. The mean width of tissue cuff biopsied was 1.3 cm (range, 0.9-2.0 cm). Nine imaging-guided biopsies were performed in eight patients. Five biopsies were performed with color Doppler ultrasound and four with CT fluoroscopy. There was a median of two needle passes per procedure (range, 1-4). In six cases, a diagnosis of pancreatic adenocarcinoma was made at the first biopsy session. In one patient, ultrasound-guided biopsy was negative, but subsequent CT-guided biopsy was positive. In one additional patient with chronic pancreatitis, biopsy revealed benign fibrous tissue. There were no procedure-related complications. In patients with suspected pancreatic cancer (but without a focal parenchymal mass), imaging-guided biopsy of isolated periarterial tissue cuffs of tumor is accurate and safe.